In February 2025, Gan & Lee Pharmaceuticals (hereafter referred to as "Gan & Lee," stock code: 603087.SH) unveiled that the first participant was successfully dosed in a large-scale Phase 3 clinical trial (OPTIMUM-2) of Bofanglutide, a bi-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) independently, in Chinese participant with type 2 diabetes mellitus (T2DM)
Limited Batch Release Only While Stock Lasts 99% Purity Research Use Only Bulk Discounts: Buy 3, save 10% Buy 5, save 15% Free Bonus: Beginners Guide to Peptides (52-page eBook) FREE ($29 value) with every order High-purity laboratory peptide supplied with certified COAs and independent third-party testing documentation for advanced research use
The results showed a 20% reduction in the risk of a composite of cardiovascular death, nonfatal myocardial infarction (MI) or nonfatal stroke relative to placebo over approximately 40 months of follow-up
GLP-1 receptors are expressed in the heart muscle cells, immune system cells in the heart, and in the lining of blood vessels.[ref] GLP-1 RAs have been shown to help in heart failure and also to have beneficial effects on heart rhythm.[ref] Related article : Cardiovascular disease genetic risk factors Cancer Research: Retatrutide, a GLP-1/GIP/GCG triple agonist, has recently been shown to reduce pancreatic tumor mass in animals
Further, direct stimulation of the GLP-1 receptor on cholangiocytes can lead to enhanced cellular proliferation and an elevated likelihood of cholestasis [47]
You dont need to mix them into something like a smoothie or food, and unlike multivitamins in pill or capsule form, you dont need to have a drink on hand to take them
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
